Publications by authors named "Weiling Xu"

Claim this Profile
C
Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study.
Dong Liang, Yurong Yan, Shenrui Bai, Weiling Xu, Qiaoli Wang

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion.
Xuan Liu, Weiling Xu, Zhen Li, Rongqing Li, Jin Chen

Cancer Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study.
Dong Liang, Yurong Yan, Qiaoli Wang, Shenrui Bai, Weiling Xu

Hematol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbations.
Weiling Xu, Yun Soo Hong, Bo Hu, Suzy A A Comhair, Allison J Janocha

J Allergy Clin Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 2D and 3D radiomics features with conventional features based on contrast-enhanced CT images for preoperative prediction the risk of thymic epithelial tumors.
Yu-Hang Yuan, Hui Zhang, Wei-Ling Xu, Dong Dong, Pei-Hong Gao

Radiol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia responses in arginase 2 deficient mice enhance cardiovascular health.
Weiling Xu, Kewal Asosingh, Allison J Janocha, Evan Madden, Nicholas Wanner

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma.
Xinyue Liang, Weiling Xu, Fan Zhou, Wenyang Huang, Xingcheng Yi, Jingxuan Wang

Am J Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study.
Dong Liang, Yurong Yan, Shenrui Bai, Weiling Xu, Qiaoli Wang

BMC Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis.
Weiling Xu, Xinyue Liang, Shanshan Liu, Xingcheng Yi, Mengru Tian, Jingxuan Wang, Jiayi Xu

Clin Med (Lond)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wavelet Coherence Analysis of Post-Stroke Intermuscular Coupling Modulated by Myoelectric-Controlled Interfaces.
Xinyi He, Wenbo Sun, Rong Song, Weiling Xu

Bioengineering (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method for depletion of mitochondria DNA in human bronchial epithelial cells.
Michael V Novotny, Weiling Xu, Anny Mulya, Allison J Janocha, Serpil C Erzurum

MethodsX· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study.
Yingjie Zhang, Xinyue Liang, Weiling Xu, Xingcheng Yi, Rui Hu, Jingxuan Wang

J Hematol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA Copy Number Variation in Asthma Risk, Severity, and Exacerbations.
Weiling Xu, Yun Soo Hong, Bo Hu, Suzy A A Comhair, Allison J Janocha

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.
Mengru Tian, Xinyue Liang, Weiling Xu, Xingcheng Yi, Tingting Yue, Jingxuan Wang

Ann Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method for Depletion of Mitochondria DNA in Human Bronchial Epithelial Cells.
Michael V Novotny, Weiling Xu, Anny Mulya, Allison J Janocha, Serpil C Erzurum

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma.
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma.
Peiyu Yang, Fan Zhou, Yujun Dong, Guangxun Gao, Hua Xue, Weiling Xu

Hemasphere· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma.
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Jingxuan Wang

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
Peiyu Yang, Haimin Chen, Xinyue Liang, Weiling Xu, Shanshan Yu, Mengxue Zhang

Am J Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk.
Zeneng Wang, Weiling Xu, Suzy A A Comhair, Xiaoming Fu, Zhili Shao

Am J Physiol Lung Cell Mol Physiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the synthesis and performance of a simple colorimetric and fluorescent chemosensor for Cu with good reversibility.
Bin Wang, Weiling Xu, Kaifeng Gan, Ke Xu, Qiaojie Chen

Spectrochim Acta A Mol Biomol Spectrosc· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma.
Peiyu Yang, Fan Zhou, Yujun Dong, Guangxun Gao, Hua Xue, Weiling Xu

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Comparison of whole genome sequencing and targeted sequencing for mitochondrial DNA" [Mitochondrion 58 (2021) 303-310].
Ruoying Chen, Micheala A Aldred, Weiling Xu, Joe Zein, Peter Bazeley

Mitochondrion· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis.
Dong Dong, Jin-Yu Shi, Xiao Shang, Bo Liu, Wei-Ling Xu

Medicine (Baltimore)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension.
Kewal Asosingh, Suzy Comhair, Lori Mavrakis, Weiling Xu, Dean Horton

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis